Teduglutide for Small Bowel Syndrome: A Single-Center Obervational Study
Background: Short bowel syndrome (SBS) is a debilitating condition requiring long-term parenteral support. Teduglutide is being used to enhance intestinal adaptation and reduce dependence on parenteral nutrition. This single-center observational study evaluates the real-world effectiveness of teduglutide in SBS patients.
Authors
- Martin W. von Websky
- Gun‐Soo Hong (ORCID: https://orcid.org/0000-0002-8780-3505)
- Jörg C. Kalff (ORCID: https://orcid.org/0000-0001-5160-8671)
- Peter Sebastian Keller
- Verena Stolz
- Konstantin Schürheck
Institutions
- University Hospital Bonn (DE)
- Universitätsklinikum Aachen (DE)
Publication Details
- Journal
- Intestinal failure.
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.intf.2025.100217
- Primary Topic
- Clinical Nutrition and Gastroenterology
- Type
- article
- Field-Weighted Citation Impact
- 0.00